AtomicSoftware Raises $3.8M Series C Round

i14

i14 builds new AI architectures underpinned by our team's decades of computational cognitive science research. Harnessing these principles we've developed architectures that are orders of magnitude more efficient (training and inference), get better continuously and succeed on complex, long-range complex tasks where others fail. Our architectures open up a new frontier of AI; where models and agents are small and efficient enough that they can be easily built owned and run by anyone, anywhere. Models and agents that learn each company or user's specific needs - getting better continuously as they learn from their experiences and environment.

GPN Vaccines

GPN Vaccines is a clinical-stage company focused on creating innovative vaccines that offer robust protection against the world's most important bacterial pathogens.

Stemora, Inc.

Stemora is a preclinical-stage biotechnology company developing a one-step, disease-modifying regenerative therapy for osteoarthritis. The therapy activates the body's own skeletal stem cells to regenerate native hyaline cartilage, addressing the root cause of osteoarthritis rather than just managing symptoms. The company holds an exclusive worldwide license from Stanford University and is pursuing an FDA 505(b)(2) regulatory pathway.